Areas of focus

We concentrate our research and development efforts on our core disease areas listed below and are pursuing multiple therapeutic research strategies and modalities for these areas.

Innovative science is our passion. Transformational medicines are our goal. Bristol Myers Squibb is committed to discovering, developing and delivering transformational medicines in areas where we believe we have an opportunity to make a meaningful difference for patients.

Therapeutic areas

Oncology

Oncology

We have pioneered breakthrough medicines that have helped change survival expectations for patients with solid tumor cancers...

Hematology

Hematology

At Bristol Myers Squibb, we’re advancing blood cancer treatments that have transformational potential...

Immunology

Immunology

Bristol Myers Squibb is committed to developing transformational therapies that will lead to long-lasting remission...

Cardiovascular

Cardiovascular

Our deep and long-standing commitment to cardiovascular disease began more than 60 years ago...

Neuroscience

Neuroscience

At Bristol Myers Squibb, we are committed to the development of transformational therapeutics for people with neurodegenerative, neuroinflammatory and neuromuscular diseases...

Drug platforms

Antibody-drug conjugates

Antibody-drug conjugates

By tethering a small molecule to a biologic, antibody-drug conjugates are engineered . . .

Biologics

Biologics

Biologics are large molecules produced from living organisms . . .

Cell therapy

Cell therapy

We have a broad portfolio of CAR T and TCR constructs within...

Drug delivery technology

Drug delivery technology

Novel technologies that will safely and effectively deliver . . .

Epigenetics

Epigenetics

We are working to develop a diverse array of therapeutics to target all...

Gene therapy

Gene therapy

Gene therapy delivers modified DNA to correct, repair or replace a defective disease-causing gene . . .

Millamolecules

Millamolecules

Millamolecules are mid-range compounds that fall in size between small molecules and biologics . . .

Protein homeostasis

Protein homeostasis

We are working to develop cancer treatments directed at key biological...

RNA oligonucleotides

RNA oligonucleotides

Short strands of nucleic acids synthesized . . .

Small molecules

Small molecules

These are organic compounds that are relatively small in size . . .